- Home
- APLT vs GPRO Comparison
APLT vs GPRO Comparison
Compare APLT & GPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- GPRO
- Stock Information
- Founded
- APLT 2016
- GPRO 2004
- Country
- APLT United States
- GPRO United States
- Employees
- APLT N/A
- GPRO N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- GPRO Industrial Machinery/Components
- Sector
- APLT Health Care
- GPRO Consumer Discretionary
- Exchange
- APLT Nasdaq
- GPRO Nasdaq
- Market Cap
- APLT 178.6M
- GPRO 194.6M
- IPO Year
- APLT 2019
- GPRO 2014
- Fundamental
- Price
- APLT $1.05
- GPRO $2.20
- Analyst Decision
- APLT Buy
- GPRO
- Analyst Count
- APLT 5
- GPRO 0
- Target Price
- APLT $4.13
- GPRO N/A
- AVG Volume (30 Days)
- APLT 11.8M
- GPRO 13.3M
- Earning Date
- APLT 11-06-2025
- GPRO 11-06-2025
- Dividend Yield
- APLT N/A
- GPRO N/A
- EPS Growth
- APLT N/A
- GPRO N/A
- EPS
- APLT N/A
- GPRO N/A
- Revenue
- APLT $121,000.00
- GPRO $746,731,000.00
- Revenue This Year
- APLT N/A
- GPRO N/A
- Revenue Next Year
- APLT $5,931.24
- GPRO $9.72
- P/E Ratio
- APLT N/A
- GPRO N/A
- Revenue Growth
- APLT N/A
- GPRO N/A
- 52 Week Low
- APLT $0.30
- GPRO $0.40
- 52 Week High
- APLT $10.62
- GPRO $3.05
- Technical
- Relative Strength Index (RSI)
- APLT 66.45
- GPRO 55.52
- Support Level
- APLT $0.56
- GPRO $2.14
- Resistance Level
- APLT $1.32
- GPRO $2.51
- Average True Range (ATR)
- APLT 0.17
- GPRO 0.26
- MACD
- APLT 0.05
- GPRO -0.05
- Stochastic Oscillator
- APLT 73.60
- GPRO 18.83
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.